Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/30/1997WO1997039726A1 Oxa diacids and related compounds for treating skin conditions
10/30/1997WO1997039721A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997WO1997039641A1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive
10/30/1997WO1997035997A3 Recombinant pox virus encoding myelin protein for therapy
10/30/1997WO1997035989A3 Cyclic nucleotide phosphodiesterase
10/30/1997WO1997032998A3 Materials and methods relating to the identification of a polymorphism associated with disease susceptibility
10/30/1997WO1997021720A3 Processes for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and intermediates useful therein and a general process for the epoxidation of olifinic double bonds
10/30/1997WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10/30/1997DE19713141A1 Transdermal plaster
10/30/1997DE19654186A1 Verbindungen zur Behandlung von Tumoren und deren Verwendung zur Herstellung von Arzneimitteln Compounds for the treatment of tumors and the use thereof for the preparation of medicaments
10/30/1997DE19617864A1 Neue chirale Phenyldihydrofuranone New chiral Phenyldihydrofuranone
10/30/1997DE19616585A1 Complex of cyclodextrin or derivative and 3-deoxy-D-glycero-pentulose
10/30/1997DE19616486A1 Verfahren zur Senkung des Blutglukosespiegels in Säugern A method for lowering blood glucose levels in mammals
10/30/1997DE19616471A1 Phosponsäureester zur Behandlung von Hirnleistungsstörungen und Depressionen Phosponsäureester for the treatment of brain disorders and depression
10/30/1997CA2429726A1 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/30/1997CA2252964A1 Pyrazinone thrombin inhibitors
10/30/1997CA2252835A1 Chicken embryo lethal orphan (celo) virus
10/30/1997CA2252778A1 Phosphate mimics
10/30/1997CA2252761A1 Compounds with growth hormone releasing properties
10/30/1997CA2252643A1 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997CA2252581A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997CA2252573A1 Heterocyclic compounds
10/30/1997CA2252567A1 Use of phosphonic acid esters for the treatment of functional disorders of the brain and depression
10/30/1997CA2252563A1 Heterocyclic compounds and their preparation and use
10/30/1997CA2252527A1 Heterocyclic compounds
10/30/1997CA2252494A1 Compositions comprising a nitrone compound for use in treating ocular inflammation
10/30/1997CA2252439A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997CA2252385A1 Piperidines and pyrrolidines
10/30/1997CA2252116A1 N-3 substituted pyrimidin-4-ones with aii antagonistic activity
10/30/1997CA2252088A1 Secreted proteins and polynucleotides encoding them
10/30/1997CA2251989A1 Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands
10/30/1997CA2251974A1 Heterocyclic compounds
10/30/1997CA2251832A1 Simian-human hav having a chimeric 2c protein
10/30/1997CA2251808A1 Methods for inducing bone formation
10/30/1997CA2251714A1 Suppression of immune response via inhibition of cathepsin s
10/30/1997CA2251680A1 Novel peptides suitable for use in antigen specific immunosuppressive therapy
10/30/1997CA2251584A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
10/30/1997CA2251356A1 Component b as cicatrizant
10/30/1997CA2250921A1 Modified ligands of calcium-dependent binding proteins
10/30/1997CA2250873A1 Heterocyclic compounds
10/30/1997CA2250869A1 Combination therapy for treatment of erectile dysfunction
10/30/1997CA2250856A1 Treatment of mood/affective disorders by glutamatergic upmodulators
10/30/1997CA2250472A1 Heterocyclic compounds
10/30/1997CA2249029A1 Thienopyridine derivatives and their use
10/30/1997CA2175313A1 Tricyclic derivatives, compositions and methods of use
10/30/1997CA2175287A1 Tricyclic derivatives, compositions and methods of use
10/30/1997CA2175282A1 Use of forms of hyaluronic acid (ha) for the treatment of cancer
10/29/1997EP0803576A2 Process for the production of lipstatin and tetrahydrolipstatin
10/29/1997EP0803506A1 Process for the preparation of 3-halogenocephem derivatives
10/29/1997EP0803505A1 Inhibitors of metalloproteases, process for their preparation and pharmaceutical compositions containing them
10/29/1997EP0803503A1 Acids and esters of diosmetin and pharmaceutical compositions containing them
10/29/1997EP0803501A1 Substituted guanidine derivatives and their use as Na+/H+ exchange inhibitors
10/29/1997EP0803254A1 Alcoholic solutions containing acetylsalicylic acid for percutaneous administration, their use in antithrombotic therapy and medicaments
10/29/1997EP0803253A1 Matrix-type oral sustained-release tablets containing tianeptine sodium salt
10/29/1997EP0803252A2 Treatment of central nervous system disorders with imidazole angiotensin-II receptor antagonists
10/29/1997EP0803251A1 Immediate release pH-independent solid dosage form of cisapride
10/29/1997EP0803250A1 Controlled release of steroids from sugar coatings
10/29/1997EP0803249A2 Cholesterol lowering drink mix compositions
10/29/1997EP0803192A1 Antimycotic ectoparasiticidal product for external use
10/29/1997EP0802976A2 Stabilized external guide sequences
10/29/1997EP0802972A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
10/29/1997EP0802921A1 Human pak65
10/29/1997EP0802920A2 Antifungal fusacandins
10/29/1997EP0802917A1 Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents
10/29/1997EP0802916A1 Low molecular weight bicyclic thrombin inhibitors
10/29/1997EP0802915A1 Camptothecin derivatives and its manufacturing method
10/29/1997EP0802914A1 Aryl and heteroaryl purine compounds
10/29/1997EP0802913A1 IMIDAZO 4,5-c]QUINOLINE AMINES
10/29/1997EP0802912A1 Piperidine derivatives having tachykinin antagonist activity
10/29/1997EP0802911A1 Hydrophobic taxane derivatives
10/29/1997EP0802910A1 Estrogen agonists/antagonists
10/29/1997EP0802909A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/29/1997EP0802908A1 Novel compounds
10/29/1997EP0802902A1 Indole derivatives useful in the treatment of osteoporosis
10/29/1997EP0802901A1 Novel carbamate compounds containing thiocarbamoyl group and process for preparing the same
10/29/1997EP0802900A1 Antiarrhythmic (s)-enantiomers of methanesulfonamides
10/29/1997EP0802899A1 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane
10/29/1997EP0802897A1 Novel compounds
10/29/1997EP0802797A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
10/29/1997EP0802794A1 Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
10/29/1997EP0802793A1 Use of carbostyril compounds for inhibition of tnf-alpha
10/29/1997EP0802792A1 Therapeutic treatment for inhibiting vascular restenosis
10/29/1997EP0802791A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
10/29/1997EP0802790A1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts
10/29/1997EP0802789A1 Plaster containing estradiol
10/29/1997EP0802784A1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof
10/29/1997EP0802783A1 Topical preparations containing l-arginine
10/29/1997EP0802782A1 Prophylactic and therapeutic treatment of skin sensitization and irritation
10/29/1997EP0802731A1 Prophylactic treatment of allergic contact dermatitis
10/29/1997EP0759744A4 Narcotic containing aerosol formulation
10/29/1997EP0679154B1 New crystalline form of a vitamin d analogue
10/29/1997EP0637976B1 Medicament for disinfection of the oral cavity
10/29/1997EP0636136B1 2-aminosugar derivatives of macrolides
10/29/1997EP0619825B1 A method for preparing enteric-coated oral drugs containing acid-unstable compounds
10/29/1997EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997EP0471756B1 Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
10/29/1997EP0429685B1 Oxoindole derivative
10/29/1997CN1163616A Dc107衍生物 Dc107 derivatives
10/29/1997CN1163615A Bicyclic oxazine and thiazine oxazolidinone antibacterials
10/29/1997CN1163613A 7-azabicyclo£2,2,1|-heptane and heptene derivatives as cholinergic receptor ligands
1 ... 6731 6732 6733 6734 6735 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 6746 6747 6748 6749 6750 6751 ... 7860